Journal of Pharmacy and Pharmaceutical Sciences

Papers
(The TQCC of Journal of Pharmacy and Pharmaceutical Sciences is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Current Drugs with Potential for Treatment of COVID-19: A Literature Review69
Prevention and therapy of COVID-19 via exogenous estrogen treatment for both male and female patients68
Therapeutic potential of ivermectin as add on treatment in COVID 19: A systematic review and meta-analysis45
Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes38
Evaluation of Ivermectin as a Potential Treatment for Mild to Moderate COVID-19: A Double-Blind Randomized Placebo Controlled Trial in Eastern India35
Progress and Prospects of Research Ideas and Methods in the Network Pharmacology of Traditional Chinese Medicine30
Gamma glutamyl transferase – an underestimated marker for cardiovascular disease and the metabolic syndrome30
Pyrrole as an Important Scaffold of Anticancer Drugs: Recent Advances28
Monkeypox: Virology, Pathophysiology, Clinical Characteristics, Epidemiology, Vaccines, Diagnosis, and Treatments25
A Sensitive Aptamer-Based Biosensor for Electrochemical Quantification of PSA as a Specific Diagnostic Marker of Prostate Cancer24
Solid Lipid Nanoparticles: An Approach to Improve Oral Drug Delivery21
RECENT ADVANCES IN ELASTIN-BASED BIOMATERIALS20
Safety and Efficacy of Remdesivir for the Treatment of COVID-19: A Systematic Review and Meta-Analysis20
Targeted Nanomedicines for Cancer Therapy, From Basics to Clinical Trials19
Potential Application of Ionic Liquids in Pharmaceutical Dosage Forms for Small Molecule Drug and Vaccine Delivery System19
Assessing the Elevation of Cardiac Biomarkers and the Severity of COVID-19 Infection: A Meta-analysis17
Simulation of Remdesivir Pharmacokinetics and Its Drug Interactions17
Efficacy of Cetirizine 1% Versus Minoxidil 5% Topical Solution in the Treatment of Male Alopecia: A Randomized, Single-blind Controlled Study17
Pharmacovigilance Evaluation of Bendamustine-related Skin Disorders using the Japanese Adverse Drug Event Report Database14
Anti-Inflammatory Properties of Drugs Used to Control COVID-19 and their Effects on the Renin-Angiotensin System and Angiotensin-Converting Enzyme-213
Cannabis and the Gastrointestinal Tract12
The Human Microbiome: History and Future12
Health Canada Usage of Real World Evidence (RWE) in Regulatory Decision Making compared with FDA/EMA usage based on publicly available information11
Effects of Vitamin D Serum Level on Morbidity and Mortality in Patients with COVID-19: A Systematic Review and Meta-Analysis11
Association Between Vitamin D Levels and Inflammatory Markers in COVID-19 Patients: A Meta-Analysis of Observational Studies11
Losartan Inhibits SARS-CoV-2 Replication in Vitro11
Simultaneous Determination of Docetaxel and Celecoxib in Porous Microparticles and Rat Plasma by Liquid-Liquid Extraction and HPLC with UV Detection: in vitro and in vivo Validation and Application10
Recent Advances in Oral Mucoadhesive Drug Delivery10
Medical Marijuana Effects in Movement Disorders, Focus on Huntington Disease; A Literature Review9
Pharmacokinetics and Toxicokinetics Roles of Membrane Transporters at Kidney Level9
Lopinavir/Ritonavir for COVID-19: a Systematic Review and Meta-Analysis9
The Lymphatic System: A Sometimes-Forgotten Compartment in Pharmaceutical Sciences8
Effects of anti-allergy drugs on Th1 cell and Th2 cell development mediated by Langerhans cells8
miR-484: A Possible Indicator of Drug-Induced Pulmonary Fibrosis8
Topical Application of Doxycycline Inhibits Th2 Cell Development Mediated by Langerhans Cells and Exerts a Therapeutic Effect on Atopic Dermatitis8
Genotype-Guided Antiplatelet Therapy Versus Standard Therapy for Patients with Coronary Artery Disease: An Updated Systematic Review and Meta-Analysis8
Research progress on vesicle cycle and neurological disorders8
ADVANCES OF NON-IRON METAL NANOPARTICLES IN BIOMEDICINE8
0.025842905044556